Bioaccumulation of gamma emitting radionuclides in .

J Radioanal Nucl Chem

Institute of Meteorology and Water Management, National Research Institute, Maritime Branch in Gdynia, Waszyngtona 42, 81-342 Gdynia, Poland.

Published: October 2013

The article presents the results of a study on the bioaccumulation abilities of , a red algae specific to the southern Baltic Sea, towards (of) gamma emitting isotopes. A laboratory experiment was carried out to determine changes in the activities of some isotopes-Mn, Co, Zn, Ag,Sn, Cs, Cs and Am-occurring in exposed to a seawater medium containing these isotopes over the course of 1 month. All analyzed isotopes showed the greatest increase of radioactive activity in plant tissue in the first 24 h of exposure. The temporary concentration factors of cesium isotopes were increasing linearly during the experiment from 114 to 274 in the case of Cs, and from 144 to 351 in the case of Cs. The level of the initial concentration factor of cesium isotopes in the plant proved to be independent of the initial concentration of the isotope in seawater and it took the lowest (125 dm kg) level among the studied isotopes. In the case of a mixture of gamma emitting isotopes, a linear relation between the individual isotope activity in and its initial concentration in seawater was established after the first day of exposure; the isotopes initial concentration factors ranged from 767 to 874 dm kg. Having reached the maximal concentration level, a statistically significant decline in radioactivity concentrations of the five isotopes in the plant tissue was observed. A half-life of biological removal of the isotopes from the plant tissue was established at: 3.8 days in the case of Mn, 4 days-Co, 4 days-Co, 4.2 days-Cs and Am-3.5 days.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514610PMC
http://dx.doi.org/10.1007/s10967-013-2794-2DOI Listing

Publication Analysis

Top Keywords

initial concentration
16
gamma emitting
12
plant tissue
12
isotopes plant
12
isotopes
10
emitting isotopes
8
concentration factors
8
cesium isotopes
8
concentration
6
bioaccumulation gamma
4

Similar Publications

Introduction: Therapeutic drug monitoring (TDM) in inflammatory rheumatic diseases (RMDs) is gaining interest. However, there are unresolved questions about the best practices for implementing TDM effectively in clinical settings.

Objective: The primary objective of this study was to evaluate whether early TDM of adalimumab predicts drug survival at 52 weeks in patients with RMDs.

View Article and Find Full Text PDF

Background: Healthcare resources have been concentrated in urban areas, leaving rural regions vulnerable to poorer health outcomes. The Problem Solving for Better Health (PSBH) program was implemented to enhance healthcare systems in resource-limited regions by training personnel to maximize existing resources in problem-solving. This study evaluated the implementation effectiveness of PSBH-Nursing (PSBHN), a nationally led initiative to train nurses in PSBH in Lesotho.

View Article and Find Full Text PDF

Rapid Development of High Concentration Protein Formulation Driven by High-Throughput Technologies.

Pharm Res

January 2025

BioDev Department WuXi Biologics USA, 1 Cedarbrook Dr, Cranbury, NJ, 08512, USA.

Background: High concentration protein formulation (HCPF) development needs to balance protein stability attributes such as conformational/colloidal stability, chemical stability, and solution properties such as viscosity and osmolality.

Methodology: A three-phase design is established in this work. In Phase 1, conformational and colloidal stability are measured by 384-well-based high-throughput (HT) biophysical screening while viscosity reduction screening is performed with HT viscosity screening.

View Article and Find Full Text PDF

Clinical trials demonstrate the short-term efficacy of dual CFTR modulators, but long-term real-world data is limited. We aimed to investigate the effects of 24-month lumacaftor/ivacaftor (LUM/IVA) therapy in pediatric CF patients (pwCF). This observational study included pwCF homozygous for F508del mutation treated between 2021 and 2023.

View Article and Find Full Text PDF

The present study was aimed at revealing the metabolic changes that occurred in the cellular lipid pattern of acute and chronic myeloid leukaemia cells following treatment with cannabidiol (CBD). CBD is a non-psychoactive compound present in Cannabis sativa L., which has shown an antiproliferative action in these type of cancer cells.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!